1,905 Shares in Guardian Pharmacy Services, Inc. $GRDN Acquired by Parkside Financial Bank & Trust

Parkside Financial Bank & Trust acquired a new position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 1,905 shares of the company’s stock, valued at approximately $41,000.

Several other large investors have also recently added to or reduced their stakes in the stock. Envestnet Asset Management Inc. boosted its holdings in shares of Guardian Pharmacy Services by 7.1% during the second quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock valued at $258,000 after acquiring an additional 805 shares during the period. Allspring Global Investments Holdings LLC lifted its position in Guardian Pharmacy Services by 0.5% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 285,885 shares of the company’s stock valued at $6,092,000 after purchasing an additional 1,338 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in Guardian Pharmacy Services during the 2nd quarter valued at about $75,000. Meeder Asset Management Inc. bought a new position in Guardian Pharmacy Services in the 1st quarter worth about $88,000. Finally, Woodline Partners LP increased its stake in shares of Guardian Pharmacy Services by 1.5% in the first quarter. Woodline Partners LP now owns 421,203 shares of the company’s stock valued at $8,955,000 after purchasing an additional 6,083 shares during the period.

Analysts Set New Price Targets

GRDN has been the subject of several analyst reports. Wall Street Zen downgraded Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a research report on Sunday. Weiss Ratings upgraded Guardian Pharmacy Services from a “sell (d+)” rating to a “hold (c)” rating in a research report on Tuesday. Truist Financial increased their price target on Guardian Pharmacy Services from $28.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, September 26th. Finally, Oppenheimer initiated coverage on shares of Guardian Pharmacy Services in a research note on Friday, October 10th. They set an “outperform” rating and a $30.00 price objective on the stock. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $29.33.

Guardian Pharmacy Services Stock Up 1.2%

Shares of GRDN stock opened at $31.63 on Thursday. The stock has a 50-day simple moving average of $26.98 and a 200 day simple moving average of $24.02. The stock has a market capitalization of $2.00 billion, a P/E ratio of 50.21 and a beta of 0.96. Guardian Pharmacy Services, Inc. has a fifty-two week low of $17.78 and a fifty-two week high of $37.43.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings results on Monday, November 10th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.24 by $0.01. Guardian Pharmacy Services had a net margin of 2.90% and a return on equity of 30.29%. The firm had revenue of $377.43 million for the quarter, compared to analysts’ expectations of $381.16 million. Guardian Pharmacy Services has set its FY 2025 guidance at EPS. On average, sell-side analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.